Cardiac Pharmacology

Last Updated: 9 June 2017

This virtual issue of Pharmacology Research & Perspectives focuses on cardiovascular pharmacology, and demonstrates the breadth of work we publish in this area.  From characterizing the effects of an immunosuppressive drug on cardiac metabolism to advances in understanding of the mechanism of action of beta adrenergic and angiotensin inhibiting drugs to systems models for the characterization of clinical electrocardiographic QT prolongation, the journal provides an attractive venue for publication of original cardiovascular pharmacology research.  These high quality contributions to the literature offer a place for the Pharmacology Research & Perspectives reader to advance their knowledge, and for the author to have their work widely disseminated.  We encourage potential authors to review these excellent papers as they consider a venue for their cardiovascular pharmacology research.
Brief Detailed

In Memoriam: Darrell R. Abernethy, M.D. Ph.D.

It is with deep sadness that the Editorial Team at PR&P must convey the news that Darrell Abernethy, Editor in Chief of the Journal, has recently passed away. Darrell has been instrumental in raising the profile and quality of PR&P in both his roles on the Journal, first as Deputy Editor and then Editor. He has been a true inspiration to so many of our authors and editors who work in the field of pharmacology, very much a team player, providing considered and thoughtful responses. His wise counsel will be missed.

Rest in peace

PR&P Editorial Team

Darrell's obituary can be viewed on the ASPET website